Polypill for Cardiovascular Disease Prevention in an Underserved Population. | Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC)

Muñoz D, Uzoije P, Reynolds C, Miller R, Walkley D, Pappalardo S, Tousey P, Munro H, Gonzales H, Song W, White C, Blot WJ, Wang TJ. Polypill for Cardiovascular Disease Prevention in an Underserved Population. The New England journal of medicine. 2019 Dec 19;381(381). 1114-1123. PMID: 31532959 [PubMed] PMCID: PMC6938029 NIHMSID: NIHMS1064213.

Abstract

Persons with low socioeconomic status and nonwhite persons in the United States have high rates of cardiovascular disease. The use of combination pills (also called "polypills") containing low doses of medications with proven benefits for the prevention of cardiovascular disease may be beneficial in such persons. However, few data are available regarding the use of polypill therapy in underserved communities in the United States, in which adherence to guideline-based care is generally low.